WILD vs. CGX, ZUM, CGO, RAY.A, FORA, Y, PNC.B, EQ, AXV, and GAME
Should you be buying WildBrain stock or one of its competitors? The main competitors of WildBrain include Cineplex (CGX), ZoomerMedia (ZUM), Cogeco (CGO), Stingray Group (RAY.A), VerticalScope (FORA), Yellow Pages (Y), Postmedia Network Canada Corp Class NC (PNC.B), EQ (EQ), Axion Ventures (AXV), and GameSquare (GAME). These companies are all part of the "communication services" sector.
WildBrain vs.
WildBrain (TSE:WILD) and Cineplex (TSE:CGX) are both small-cap communication services companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation, institutional ownership, community ranking and media sentiment.
45.4% of WildBrain shares are owned by institutional investors. Comparatively, 24.3% of Cineplex shares are owned by institutional investors. 1.3% of WildBrain shares are owned by insiders. Comparatively, 1.9% of Cineplex shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
WildBrain has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500. Comparatively, Cineplex has a beta of 2.74, suggesting that its share price is 174% more volatile than the S&P 500.
WildBrain pays an annual dividend of C$0.08 per share and has a dividend yield of 4.3%. Cineplex pays an annual dividend of C$1.80 per share and has a dividend yield of 18.3%. WildBrain pays out -9.3% of its earnings in the form of a dividend. Cineplex pays out -302.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cineplex is clearly the better dividend stock, given its higher yield and lower payout ratio.
Cineplex has a net margin of -2.83% compared to WildBrain's net margin of -38.77%. WildBrain's return on equity of 3,013.26% beat Cineplex's return on equity.
WildBrain currently has a consensus price target of C$1.88, indicating a potential upside of 0.71%. Cineplex has a consensus price target of C$20.00, indicating a potential upside of 103.25%. Given Cineplex's stronger consensus rating and higher possible upside, analysts plainly believe Cineplex is more favorable than WildBrain.
Cineplex received 776 more outperform votes than WildBrain when rated by MarketBeat users. Likewise, 72.52% of users gave Cineplex an outperform vote while only 20.00% of users gave WildBrain an outperform vote.
In the previous week, WildBrain and WildBrain both had 1 articles in the media. WildBrain's average media sentiment score of 0.07 beat Cineplex's score of 0.00 indicating that WildBrain is being referred to more favorably in the media.
Cineplex has higher revenue and earnings than WildBrain. Cineplex is trading at a lower price-to-earnings ratio than WildBrain, indicating that it is currently the more affordable of the two stocks.
Summary
Cineplex beats WildBrain on 13 of the 19 factors compared between the two stocks.
Get WildBrain News Delivered to You Automatically
Sign up to receive the latest news and ratings for WILD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
WildBrain Competitors List
Related Companies and Tools
This page (TSE:WILD) was last updated on 3/30/2025 by MarketBeat.com Staff